Patients must be the focus of innovation and they must also be active partners in all aspects of research, development and regulation of new therapies, testified Leonard Lichtenfeld, M.D., deputy chief medical officer of the American Cancer Society, before the House Energy and Commerce Subcommittee on Health today.
WASHINGTON, D.C. July 10, 2014 Following is a statement from John Seffrin, chief executive officer of the American Cancer Society and its advocacy affiliate, the American Cancer Society Cancer Action Network (ACS CAN), on the departure of Howard K.
WASHINGTON, D.C. July 2, 2014 A new report released today by the White House Council of Economic Advisors finds that millions of uninsured Americans continue to go without health coverage because several states have chosen not to increase access to Medicaid.
WASHINGTON, D.C. June 24, 2014 The Centers for Disease Control and Prevention (CDC) released new advertisements today as part of its ongoing Tips from Former Smokers national campaign. The following is a statement from John R.
Washington, DC More than 250 childhood cancer patients, survivors and their families will be on Capitol Hill on Tuesday, June 24 to ask Congress to continue to support initiatives that can improve research, treatment and outcomes for children with cancer.
WASHINGTON, DC On the fifth anniversary of the landmark 2009 law granting the Food and Drug Administration (FDA) authority over tobacco products, 10 leading public health and medical organizations today commended the FDA for the steps it has taken to reduce tobacco use and called on the FDA and
WASHINGTON, D.C. June 12, 2014 The Centers for Disease Control and Prevention (CDC) today released results from the Youth Risk Behavior Surveillance (YRBS) survey showing youth cigarette use has declined to 15.7 percent, a historic low.
WASHINGTON, DC – U.S. District Judge Gladys Kessler on Monday issued a final order detailing how major U.S.
Following is a statement from the American Cancer Society Cancer Action Network (ACS CAN) commending the Food and Drug Administration (FDA) for finalizing its order to reclassify indoor tanning devices from a class I to a class II medical device, imposing greater control over their manufacture and distribution.
WASHINGTON May 16, 2014 Critical legislation introduced last night in the U.S. Senate would ensure that cost is not a barrier for Medicare beneficiaries trying to access lifesaving colon cancer screenings.